Experimental and epidemiological studies have suggested that hyperglycaemia and hyperinsulinemia may upregulate the production and bioavailability of insulin-like growth factor-1 (IGF-1), which could promote cellular proliferation and inhibits apoptosis by receptor-mediated pathways in live cancer cells [10, 38, 39]. The gene discussed is IGF1; the disease is Hyperglycemia.